Shelia Suhr, non-small-cell lung cancer, cancer
New Treatment Results in More Time for Family
There are many people who rely upon Sheila Suhr, the 62-year-old mother of six
and grandmother to six more, to whom she devotes much of her time. So when
Sheila was diagnosed with non-small-cell lung cancer in 2001, her focus was
still family: to get better to help with a son’s wedding planning.
Fortunately, Sheila had close family friends with medical
expertise. They referred her to Dr Nasser Altorki, director of thoracic surgery
at New York-Presbyterian Hospital’s Weill Cornell Medical Center. Dr Altorki
suggested a Phase II clinical trial: treatment prior to surgery with the COX-2
inhibitor Celebrex® (celecoxib) added.
Ultimately, Sheila felt that her quality of care
was excellent. In fact, Sheila twice recommended others to the same study. But
the best part of her trial experience was the result. Sheila’s surgery showed
that her cancer was eradicated and no further treatment was necessary; she
could get on with her recovery and back to her children.
Sheila feels very lucky. “There was no messing around. My
timeline was less than four months, and it was over. I was really blessed with
the people I met and the way things moved.”